Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death.
Conticello C, Adamo L, Giuffrida R, Vicari L, Zeuner A, Eramo A, Anastasi G, Memeo L, Giuffrida D, Iannolo G, Gulisano M, De Maria R. Conticello C, et al. Among authors: giuffrida r, giuffrida d. J Clin Endocrinol Metab. 2007 May;92(5):1938-42. doi: 10.1210/jc.2006-2157. Epub 2007 Feb 27. J Clin Endocrinol Metab. 2007. PMID: 17327374
New treatment in advanced thyroid cancer.
Giuffrida D, Prestifilippo A, Scarfia A, Martino D, Marchisotta S. Giuffrida D, et al. J Oncol. 2012;2012:391629. doi: 10.1155/2012/391629. Epub 2012 Oct 22. J Oncol. 2012. PMID: 23133451 Free PMC article.
Prognostic Factors for Adrenocortical Carcinoma Outcomes.
Scollo C, Russo M, Trovato MA, Sambataro D, Giuffrida D, Manusia M, Sapuppo G, Malandrino P, Vigneri R, Pellegriti G. Scollo C, et al. Among authors: giuffrida d. Front Endocrinol (Lausanne). 2016 Jul 25;7:99. doi: 10.3389/fendo.2016.00099. eCollection 2016. Front Endocrinol (Lausanne). 2016. PMID: 27504106 Free PMC article.
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
Pusceddu S, Vernieri C, Di Maio M, Marconcini R, Spada F, Massironi S, Ibrahim T, Brizzi MP, Campana D, Faggiano A, Giuffrida D, Rinzivillo M, Cingarlini S, Aroldi F, Antonuzzo L, Berardi R, Catena L, De Divitiis C, Ermacora P, Perfetti V, Fontana A, Razzore P, Carnaghi C, Davì MV, Cauchi C, Duro M, Ricci S, Fazio N, Cavalcoli F, Bongiovanni A, La Salvia A, Brighi N, Colao A, Puliafito I, Panzuto F, Ortolani S, Zaniboni A, Di Costanzo F, Torniai M, Bajetta E, Tafuto S, Garattini SK, Femia D, Prinzi N, Concas L, Lo Russo G, Milione M, Giacomelli L, Buzzoni R, Delle Fave G, Mazzaferro V, de Braud F. Pusceddu S, et al. Among authors: giuffrida d. Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13. Gastroenterology. 2018. PMID: 29655834 Free article.
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy.
Locati LD, Piovesan A, Durante C, Bregni M, Castagna MG, Zovato S, Giusti M, Ibrahim T, Puxeddu E, Fedele G, Pellegriti G, Rinaldi G, Giuffrida D, Verderame F, Bertolini F, Bergamini C, Nervo A, Grani G, Rizzati S, Morelli S, Puliafito I, Elisei R. Locati LD, et al. Among authors: giuffrida d. Eur J Cancer. 2019 Sep;118:35-40. doi: 10.1016/j.ejca.2019.05.031. Epub 2019 Jul 9. Eur J Cancer. 2019. PMID: 31299580
Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer.
Giuffrida D, Giuffrida R, Puliafito I, Vella V, Memeo L, Puglisi C, Regalbuto C, Pellegriti G, Forte S, Belfiore A. Giuffrida D, et al. Among authors: giuffrida r. Int J Surg Oncol. 2019 Oct 13;2019:2715260. doi: 10.1155/2019/2715260. eCollection 2019. Int J Surg Oncol. 2019. PMID: 31737363 Free PMC article.
192 results